Dr Reddy’s Enters OTC Eyecare Space

US Launch Of Pataday Generic Follows Voltaren And Nicorette Rivals

Dr Reddy’s has announced the launch of its OTC versions of Pataday olopatadine solution in the US. The firm’s entry into the OTC eyecare space follows other OTC launches of rivals to Voltaren and Nicorette earlier this year.

OTC
Dr Reddy’s is hoping to reap the benefits of an OTC eyecare presence • Source: Shutterstcok

More from Generics

More from Products